The Latin America, Middle East and Africa Intravenous (IV) Therapy and Vein Access Market would witness Market growth of 7.8% CAGR during the forecast period (2022-2028).
IV therapy is advantageous for a variety of reasons, one of which is the ease with which it can be administered. If the patient does not want to go to the hospital, IV therapy is a simple and handy option. A person can eliminate unnecessary travel by opting for in-home IV therapy. IV treatment also improves wellness and good health. The IV drop, which contains minerals, water, and vitamins, can assist the patient in maintaining a healthy lifestyle and boosting his or her immune system. It also keeps the patient hydrated and increases their energy levels. In-home IV therapy has grown in popularity as a viable alternative to hospitalization as demand for hospital beds has increased and waiting lines have become interminable.
Furthermore, numerous healthcare facilities provide IV therapy as an alternative to hospitalization for patients on long-term drugs. For example, Pasithea Therapeutics Corp., a major biotechnology business, has developed Pasithea Clinics, a subsidiary that will provide in-home IV ketamine therapy to patients suffering from treatment-resistant mental health conditions. Because individuals with mental health illnesses have a hard time competing with normal routines, the minor step of in-home IV therapy would reduce their stress and allow them to get therapy in the privacy of their own home.
The Market for intravenous (IV) therapy and vein access devices in Latin America is rapidly expanding. Brazil, Mexico, and Argentina are among the countries in this region that are enjoying strong economic expansion. The regional Market is characterized by the rising prevalence of chronic diseases such as cancer and diabetes.
The Market for intravenous (IV) therapy and vein access devices in the Middle East and Africa is rapidly expanding. Saudi Arabia, South Africa, and Nigeria are among the countries in this area that are enjoying strong economic expansion. Because of the rising prevalence of chronic diseases such as cancer and diabetes, intravenous (IV) therapy and vein access devices are becoming more popular across the Middle East and Africa. Higher incidence of chronic diseases such as diabetes and cancer, expanding healthcare infrastructure, rising GDP, increased disposable income, and increased awareness of advanced therapies' availability in the region are some of the growth factors for the regional Market . Latin America's and the Middle East's and Africa's Market s are still in their infancy.
The Brazil Market dominated the LAMEA Intravenous (IV) Therapy and Vein Access Market by Country 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $554.2 million by 2028. The Argentina Market is estimated to grow at a CAGR of 8.4% during (2022 - 2028). Additionally, The UAE Market would witness a CAGR of 7.6% during (2022 - 2028).
Based on End User, the Market is segmented into Hospitals, Ambulatory Surgical Center, and Clinics. Based on Application, the Market is segmented into Medication Administration, Blood Based Products, Nutrition & Buffer Solution, and Volume Expander. Based on Type, the Market is segmented into Intravenous Catheters, Infusion Pumps, Hypodermic Needles, Implantable Ports, and Others. Based on countries, the Market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Intravenous (IV) Therapy and Vein Access Market is Predict to reach $33.6 Billion by 2028, at a CAGR of 5.3%
The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include B. Braun Melsungen AG, Medtronic PLC, Terumo Corporation, Fresenius SE & Co. KGaA, Cardinal Health, Inc., Pfizer, Inc., Teleflex, Inc., Baxter International, Inc., Smiths Group PLC, and AngioDynamics, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User
- Hospitals
- Ambulatory Surgical Center
- Clinics
By Application
- Medication Administration
- Blood Based Products
- Nutrition & Buffer Solution
- Volume Expander
By Type
- Intravenous Catheters
- Infusion Pumps
- Hypodermic Needles
- Implantable Ports
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- B. Braun Melsungen AG
- Medtronic PLC
- Terumo Corporation
- Fresenius SE & Co. KGaA
- Cardinal Health, Inc.
- Pfizer, Inc.
- Teleflex, Inc.
- Baxter International, Inc.
- Smiths Group PLC
- AngioDynamics, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Intravenous (IV) Therapy and Vein Access Market, by End User
1.4.2 LAMEA Intravenous (IV) Therapy and Vein Access Market, by Application
1.4.3 LAMEA Intravenous (IV) Therapy and Vein Access Market, by Type
1.4.4 LAMEA Intravenous (IV) Therapy and Vein Access Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Intravenous (IV) Therapy and Vein Access Market
Chapter 4. LAMEA Intravenous (IV) Therapy and Vein Access Market by End User
4.1 LAMEA Hospitals Market by Country
4.2 LAMEA Ambulatory Surgical Center Market by Country
4.3 LAMEA Clinics Market by Country
Chapter 5. LAMEA Intravenous (IV) Therapy and Vein Access Market by Application
5.1 LAMEA Medication Administration Market by Country
5.2 LAMEA Blood Based Products Market by Country
5.3 LAMEA Nutrition & Buffer Solution Market by Country
5.4 LAMEA Others Market by Country
Chapter 6. LAMEA Intravenous (IV) Therapy and Vein Access Market by Type
6.1 LAMEA Intravenous Catheters Market by Country
6.2 LAMEA Infusion Pumps Market by Country
6.3 LAMEA Hypodermic Needles Market by Country
6.4 LAMEA Implantable Ports Market by Country
6.5 LAMEA Others Market by Country
Chapter 7. LAMEA Intravenous (IV) Therapy and Vein Access Market by Country
7.1 Brazil Intravenous (IV) Therapy and Vein Access Market
7.1.1 Brazil Intravenous (IV) Therapy and Vein Access Market by End User
7.1.2 Brazil Intravenous (IV) Therapy and Vein Access Market by Application
7.1.3 Brazil Intravenous (IV) Therapy and Vein Access Market by Type
7.2 Argentina Intravenous (IV) Therapy and Vein Access Market
7.2.1 Argentina Intravenous (IV) Therapy and Vein Access Market by End User
7.2.2 Argentina Intravenous (IV) Therapy and Vein Access Market by Application
7.2.3 Argentina Intravenous (IV) Therapy and Vein Access Market by Type
7.3 UAE Intravenous (IV) Therapy and Vein Access Market
7.3.1 UAE Intravenous (IV) Therapy and Vein Access Market by End User
7.3.2 UAE Intravenous (IV) Therapy and Vein Access Market by Application
7.3.3 UAE Intravenous (IV) Therapy and Vein Access Market by Type
7.4 Saudi Arabia Intravenous (IV) Therapy and Vein Access Market
7.4.1 Saudi Arabia Intravenous (IV) Therapy and Vein Access Market by End User
7.4.2 Saudi Arabia Intravenous (IV) Therapy and Vein Access Market by Application
7.4.3 Saudi Arabia Intravenous (IV) Therapy and Vein Access Market by Type
7.5 South Africa Intravenous (IV) Therapy and Vein Access Market
7.5.1 South Africa Intravenous (IV) Therapy and Vein Access Market by End User
7.5.2 South Africa Intravenous (IV) Therapy and Vein Access Market by Application
7.5.3 South Africa Intravenous (IV) Therapy and Vein Access Market by Type
7.6 Nigeria Intravenous (IV) Therapy and Vein Access Market
7.6.1 Nigeria Intravenous (IV) Therapy and Vein Access Market by End User
7.6.2 Nigeria Intravenous (IV) Therapy and Vein Access Market by Application
7.6.3 Nigeria Intravenous (IV) Therapy and Vein Access Market by Type
7.7 Rest of LAMEA Intravenous (IV) Therapy and Vein Access Market
7.7.1 Rest of LAMEA Intravenous (IV) Therapy and Vein Access Market by End User
7.7.2 Rest of LAMEA Intravenous (IV) Therapy and Vein Access Market by Application
7.7.3 Rest of LAMEA Intravenous (IV) Therapy and Vein Access Market by Type
Chapter 8. Company Profiles
8.1 B. Braun Melsungen AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent Strategies and Developments
8.1.5.1 Product launches and Product Expansions:
8.2 Medtronic PLC
8.2.1 Company overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.3 Terumo Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.4 Fresenius SE & Co. KGaA
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent Strategies and Developments
8.4.5.1 Acquisitions and Mergers:
8.5 Cardinal Health, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.6 Pfizer, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional & Segmental Analysis
8.6.4 Research & Development Expense
8.7 Teleflex, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 Baxter International, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent Strategies and Developments
8.8.5.1 Approvals and Trials:
8.8.5.2 Acquisitions and Mergers:
8.9 Smiths Group PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent Strategies and Developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.10. AngioDynamics, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
TABLE 1 LAMEA Intravenous (IV) Therapy and Vein Access Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Intravenous (IV) Therapy and Vein Access Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Intravenous (IV) Therapy and Vein Access Market by End User, 2018 - 2021, USD Million
TABLE 4 LAMEA Intravenous (IV) Therapy and Vein Access Market by End User, 2022 - 2028, USD Million
TABLE 5 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Ambulatory Surgical Center Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Ambulatory Surgical Center Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Clinics Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Clinics Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Intravenous (IV) Therapy and Vein Access Market by Application, 2018 - 2021, USD Million
TABLE 12 LAMEA Intravenous (IV) Therapy and Vein Access Market by Application, 2022 - 2028, USD Million
TABLE 13 LAMEA Medication Administration Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Medication Administration Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Blood Based Products Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Blood Based Products Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Nutrition & Buffer Solution Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Nutrition & Buffer Solution Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Intravenous (IV) Therapy and Vein Access Market by Type, 2018 - 2021, USD Million
TABLE 22 LAMEA Intravenous (IV) Therapy and Vein Access Market by Type, 2022 - 2028, USD Million
TABLE 23 LAMEA Intravenous Catheters Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Intravenous Catheters Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Infusion Pumps Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Infusion Pumps Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Hypodermic Needles Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Hypodermic Needles Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Implantable Ports Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Implantable Ports Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Intravenous (IV) Therapy and Vein Access Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Intravenous (IV) Therapy and Vein Access Market by Country, 2022 - 2028, USD Million
TABLE 35 Brazil Intravenous (IV) Therapy and Vein Access Market, 2018 - 2021, USD Million
TABLE 36 Brazil Intravenous (IV) Therapy and Vein Access Market, 2022 - 2028, USD Million
TABLE 37 Brazil Intravenous (IV) Therapy and Vein Access Market by End User, 2018 - 2021, USD Million
TABLE 38 Brazil Intravenous (IV) Therapy and Vein Access Market by End User, 2022 - 2028, USD Million
TABLE 39 Brazil Intravenous (IV) Therapy and Vein Access Market by Application, 2018 - 2021, USD Million
TABLE 40 Brazil Intravenous (IV) Therapy and Vein Access Market by Application, 2022 - 2028, USD Million
TABLE 41 Brazil Intravenous (IV) Therapy and Vein Access Market by Type, 2018 - 2021, USD Million
TABLE 42 Brazil Intravenous (IV) Therapy and Vein Access Market by Type, 2022 - 2028, USD Million
TABLE 43 Argentina Intravenous (IV) Therapy and Vein Access Market, 2018 - 2021, USD Million
TABLE 44 Argentina Intravenous (IV) Therapy and Vein Access Market, 2022 - 2028, USD Million
TABLE 45 Argentina Intravenous (IV) Therapy and Vein Access Market by End User, 2018 - 2021, USD Million
TABLE 46 Argentina Intravenous (IV) Therapy and Vein Access Market by End User, 2022 - 2028, USD Million
TABLE 47 Argentina Intravenous (IV) Therapy and Vein Access Market by Application, 2018 - 2021, USD Million
TABLE 48 Argentina Intravenous (IV) Therapy and Vein Access Market by Application, 2022 - 2028, USD Million
TABLE 49 Argentina Intravenous (IV) Therapy and Vein Access Market by Type, 2018 - 2021, USD Million
TABLE 50 Argentina Intravenous (IV) Therapy and Vein Access Market by Type, 2022 - 2028, USD Million
TABLE 51 UAE Intravenous (IV) Therapy and Vein Access Market, 2018 - 2021, USD Million
TABLE 52 UAE Intravenous (IV) Therapy and Vein Access Market, 2022 - 2028, USD Million
TABLE 53 UAE Intravenous (IV) Therapy and Vein Access Market by End User, 2018 - 2021, USD Million
TABLE 54 UAE Intravenous (IV) Therapy and Vein Access Market by End User, 2022 - 2028, USD Million
TABLE 55 UAE Intravenous (IV) Therapy and Vein Access Market by Application, 2018 - 2021, USD Million
TABLE 56 UAE Intravenous (IV) Therapy and Vein Access Market by Application, 2022 - 2028, USD Million
TABLE 57 UAE Intravenous (IV) Therapy and Vein Access Market by Type, 2018 - 2021, USD Million
TABLE 58 UAE Intravenous (IV) Therapy and Vein Access Market by Type, 2022 - 2028, USD Million
TABLE 59 Saudi Arabia Intravenous (IV) Therapy and Vein Access Market, 2018 - 2021, USD Million
TABLE 60 Saudi Arabia Intravenous (IV) Therapy and Vein Access Market, 2022 - 2028, USD Million
TABLE 61 Saudi Arabia Intravenous (IV) Therapy and Vein Access Market by End User, 2018 - 2021, USD Million
TABLE 62 Saudi Arabia Intravenous (IV) Therapy and Vein Access Market by End User, 2022 - 2028, USD Million
TABLE 63 Saudi Arabia Intravenous (IV) Therapy and Vein Access Market by Application, 2018 - 2021, USD Million
TABLE 64 Saudi Arabia Intravenous (IV) Therapy and Vein Access Market by Application, 2022 - 2028, USD Million
TABLE 65 Saudi Arabia Intravenous (IV) Therapy and Vein Access Market by Type, 2018 - 2021, USD Million
TABLE 66 Saudi Arabia Intravenous (IV) Therapy and Vein Access Market by Type, 2022 - 2028, USD Million
TABLE 67 South Africa Intravenous (IV) Therapy and Vein Access Market, 2018 - 2021, USD Million
TABLE 68 South Africa Intravenous (IV) Therapy and Vein Access Market, 2022 - 2028, USD Million
TABLE 69 South Africa Intravenous (IV) Therapy and Vein Access Market by End User, 2018 - 2021, USD Million
TABLE 70 South Africa Intravenous (IV) Therapy and Vein Access Market by End User, 2022 - 2028, USD Million
TABLE 71 South Africa Intravenous (IV) Therapy and Vein Access Market by Application, 2018 - 2021, USD Million
TABLE 72 South Africa Intravenous (IV) Therapy and Vein Access Market by Application, 2022 - 2028, USD Million
TABLE 73 South Africa Intravenous (IV) Therapy and Vein Access Market by Type, 2018 - 2021, USD Million
TABLE 74 South Africa Intravenous (IV) Therapy and Vein Access Market by Type, 2022 - 2028, USD Million
TABLE 75 Nigeria Intravenous (IV) Therapy and Vein Access Market, 2018 - 2021, USD Million
TABLE 76 Nigeria Intravenous (IV) Therapy and Vein Access Market, 2022 - 2028, USD Million
TABLE 77 Nigeria Intravenous (IV) Therapy and Vein Access Market by End User, 2018 - 2021, USD Million
TABLE 78 Nigeria Intravenous (IV) Therapy and Vein Access Market by End User, 2022 - 2028, USD Million
TABLE 79 Nigeria Intravenous (IV) Therapy and Vein Access Market by Application, 2018 - 2021, USD Million
TABLE 80 Nigeria Intravenous (IV) Therapy and Vein Access Market by Application, 2022 - 2028, USD Million
TABLE 81 Nigeria Intravenous (IV) Therapy and Vein Access Market by Type, 2018 - 2021, USD Million
TABLE 82 Nigeria Intravenous (IV) Therapy and Vein Access Market by Type, 2022 - 2028, USD Million
TABLE 83 Rest of LAMEA Intravenous (IV) Therapy and Vein Access Market, 2018 - 2021, USD Million
TABLE 84 Rest of LAMEA Intravenous (IV) Therapy and Vein Access Market, 2022 - 2028, USD Million
TABLE 85 Rest of LAMEA Intravenous (IV) Therapy and Vein Access Market by End User, 2018 - 2021, USD Million
TABLE 86 Rest of LAMEA Intravenous (IV) Therapy and Vein Access Market by End User, 2022 - 2028, USD Million
TABLE 87 Rest of LAMEA Intravenous (IV) Therapy and Vein Access Market by Application, 2018 - 2021, USD Million
TABLE 88 Rest of LAMEA Intravenous (IV) Therapy and Vein Access Market by Application, 2022 - 2028, USD Million
TABLE 89 Rest of LAMEA Intravenous (IV) Therapy and Vein Access Market by Type, 2018 - 2021, USD Million
TABLE 90 Rest of LAMEA Intravenous (IV) Therapy and Vein Access Market by Type, 2022 - 2028, USD Million
TABLE 91 key Information – B. Braun Melsungen AG
TABLE 92 Key Information – Medtronic PLC
TABLE 93 Key Information – Terumo Corporation
TABLE 94 key information – Fresenius SE & Co. KGaA
TABLE 95 key information – Cardinal Health, Inc.
TABLE 96 Key Information – Pfizer, Inc.
TABLE 97 key Information – Teleflex, Inc.
TABLE 105 Key Information – Baxter International, Inc.
TABLE 106 Key Information – Smiths Group PLC
TABLE 107 Key Information – AngioDynamics, Inc.
List of Figures
FIG 1 Methodology for the research